by Pizarro L. BMJ Global Health 2026;11:e022292. doi: 10.1136/bmjgh-2025-022292
Summary: The alternative, non-profit model for developing health tools faces a double challenge of foreign aid cuts and structural changes in the pharmaceutical industry. These radical shifts raise concerns about the future of non-profit medical innovation. The author of this Commentary suggests some possible ways to move forward. First, challenge the false dichotomy that pits international solidarity against national interests. Second, redistribute power within the global health landscape and increase investment in the innovation capabilities of low- and middle-income countries (LMICs). Third, strengthen partnerships between the public, private, and non-profit sectors. Finally, in countries without resources to develop autonomous R&D infrastructure, develop regional partnerships between high-burden countries, needs-driven R&D organisations, donors, and industry, including small and medium enterprises from LMICs.
The post Global health is in crisis: to reach neglected patients, we need to reimagine medical research first appeared on DNDi.
Até o momento, desenvolvemos nove tratamentos para doenças negligenciadas, salvando milhões de vidas. Temos o objetivo de disponibilizar 25 novos tratamentos em nossos primeiros 25 anos. Você pode nos ajudar!
Organização internacional, sem fins lucrativos, que desenvolve tratamentos seguros, eficazes e acessíveis para os pacientes mais negligenciados.
Exceto para imagens, filmes e marcas registradas que estão sujeitos aos Termos de Uso da DNDi, o conteúdo deste site está licenciado sob uma Licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.
© 2026 - DNDi América Latina